Evolent Health Stock Today
| EVH Stock | USD 29.26 0.87 2.89% |
Performance0 of 100
| Odds Of DistressLess than 16
|
Evolent Health is trading at 29.26 as of the 25th of April 2024. This is a -2.89% down since the beginning of the trading day. The stock's open price was 30.13. Evolent Health has less than a 16 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Evolent Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 5th of June 2015 | Category Healthcare | Classification Health Care |
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. The company was founded in 2011 and is headquartered in Arlington, Virginia. The company has 113.89 M outstanding shares of which 10.61 M shares are currently shorted by investors with about 13.24 days to cover. More on Evolent Health
Moving together with Evolent Stock
| 0.74 | FONR | Fonar | PairCorr |
| 0.64 | CNC | Centene Corp Earnings Call Tomorrow | PairCorr |
Moving against Evolent Stock
| 0.46 | IRIX | IRIDEX Financial Report 9th of May 2024 | PairCorr |
| 0.42 | HSDT | Helius Medical Techn Financial Report 9th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 1st of May 2024
Evolent Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Evolent Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Evolent Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Dan McCarthy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care, NYSE Composite, Health Care, Health Care Technology, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Evolent Health report their recommendations after researching Evolent Health's financial statements, talking to executives and customers, or listening in on Evolent Health's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Evolent Health. The Evolent consensus assessment is calculated by taking the average forecast from all of the analysts covering Evolent Health. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators obtained from Evolent Health's historical financial statements, Evolent Health is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Evolent Health is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evolent Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Evolent Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Evolent Health's financial leverage. It provides some insight into what part of Evolent Health's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evolent Health (EVH) is traded on New York Stock Exchange in USA. It is located in 1812 N. Moore Street, Arlington, VA, United States, 22209 and employs 4,700 people. Evolent Health is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 3.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Evolent Health's market, we take the total number of its shares issued and multiply it by Evolent Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Evolent Health runs under Health Care Technology sector within Health Care industry. The entity has 113.89 M outstanding shares of which 10.61 M shares are currently shorted by investors with about 13.24 days to cover.
Evolent Health has about 188.2 M in cash with 142.58 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.57.
Check Evolent Health Probability Of Bankruptcy
Ownership AllocationEvolent Health retains a total of 113.89 Million outstanding shares. The majority of Evolent Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Evolent Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Evolent Health. Please pay attention to any change in the institutional holdings of Evolent Health as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Evolent Ownership Details
Evolent Stock Price Odds Analysis
Coming from a normal probability distribution, the odds of Evolent Health jumping above the current price in 90 days from now is about 91.21%. The Evolent Health probability density function shows the probability of Evolent Health stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.458 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Evolent Health will likely underperform. Additionally, evolent Health has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Evolent Health to move above the current price in 90 days from now is about 91.21 (This Evolent Health probability density function shows the probability of Evolent Stock to fall within a particular range of prices over 90 days) .
Evolent Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Evolent Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Evolent Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Evolent Health's value.| Instituion | Recorded On | Shares | |
| Eventide Asset Management, Llc | 2023-12-31 | 2.6 M | |
| Ra Capital Management, Llc | 2023-12-31 | 2.5 M | |
| State Street Corporation | 2023-12-31 | 2.5 M | |
| Bellevue Group Ag | 2023-12-31 | 2.4 M | |
| Geode Capital Management, Llc | 2023-12-31 | 2.4 M | |
| Holocene Advisors, Lp | 2023-09-30 | 2.3 M | |
| Farallon Capital Management, L.l.c. | 2023-12-31 | 2.2 M | |
| Amvescap Plc. | 2023-12-31 | 2.1 M | |
| Hood River Capital Management Llc | 2023-12-31 | 2.1 M | |
| Fmr Inc | 2023-12-31 | 12.9 M | |
| Vanguard Group Inc | 2023-12-31 | 10.8 M |
Evolent Health Historical Income Statement
Evolent Health Income Statement is one of the three primary financial statements used for reporting Evolent's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Evolent Health revenue and expense. Evolent Health Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, Evolent Health's Other Operating Expenses is increasing as compared to previous years. The Evolent Health's current EBITDA is estimated to increase to about 48.7 M, while Selling General Administrative is projected to decrease to under 236.7 M. View More FundamentalsEvolent Stock Against Markets
Picking the right benchmark for Evolent Health stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Evolent Health stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Evolent Health is critical whether you are bullish or bearish towards Evolent Health at a given time. Please also check how Evolent Health's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Evolent Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Evolent Health Corporate Directors
Evolent Health corporate directors refer to members of an Evolent Health board of directors. The board of directors generally takes responsibility for the Evolent Health's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Evolent Health's board members must vote for the resolution. The Evolent Health board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Matthew Hobart | Independent Director | Profile | |
| Bridget Duffy | Independent Director | Profile | |
| Norman Payson | Director | Profile | |
| Bruce Felt | Independent Director | Profile |
How to buy Evolent Stock?
Before investing in Evolent Health, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Evolent Health. To buy Evolent Health stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Evolent Health. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Evolent Health stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Evolent Health stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Evolent Health stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Evolent Health, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Evolent Stock please use our How to Invest in Evolent Health guide.
Already Invested in Evolent Health?
The danger of trading Evolent Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Evolent Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Evolent Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Evolent Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Evolent Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Revenue Per Share 17.653 | Quarterly Revenue Growth 0.454 | Return On Assets 0.0086 | Return On Equity (0.11) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.